Report: FivePrime CEO Out

8/18/11

Julia Gregory, the CEO of FivePrime Therapeutics, has resigned and been replaced by company founder and executive chairman Lewis “Rusty” Williams, according to a report by In Vivo, a biotech industry publication. Gregory spent two years at the company, and during her time there, struck a lucrative new partnership with Rockville, MD-based Human Genome Sciences (NASDAQ: HGSI). A year ago, in an interview with Xconomy, Gregory described FivePrime as a “biotech CEO’s dream.”

By posting a comment, you agree to our terms and conditions.